Creabilis names new CEO
Most recently, Forster was the CEO of Solace Pharmaceuticals. Before joining Solace Pharma, Forster was the head of EU Development and of Development Operations in the EU &

Most recently, Forster was the CEO of Solace Pharmaceuticals. Before joining Solace Pharma, Forster was the head of EU Development and of Development Operations in the EU &

MedQuist’s transcription solutions feed clinical documents directly into CodeRunner CAC, which helps in speeding the coding process to obtain reimbursement faster and lower a facility’s DNFBs (Discharged Not

HBI-8000 has now entered into a Phase I clinical trial in the US under an IND application with the FDA. HBI-8000 trial is designed to assess safety, tolerability

The facility is housed with three Clinical Pharmacology Units with an 80 bed facility to cater to both early and late phase development as well as life cycle

Fostamatinib (previously referred to as R788), is thought to reversibly block signalling in multiple cell types involved in inflammation and tissue degradation in RA. The first anticipated regulatory

Formed last spring by health insurer UnitedHealth Group, the alliance is anchored by Diabetes Prevention Program and Diabetes Control Program. Both of them have been tested through controlled

The first milestone is for initiation of the phase 3 clinical program with fostamatinib in patients with rheumatoid arthritis (RA) by AstraZeneca. The second milestone marks the completion

TRO40303 is indicated to reduce the cardiac reperfusion injury that contributes to the morbidity and mortality seen post myocardial infarction (MI). TRO40303 study is expected to recruit healthy

The company has posted a net loss of $4.24m for the fourth quarter 2010, or $0.40 loss per diluted share, compared to net loss of $200,530, or $0.02loss

The Vector TFC Roll Compactor is a versatile densification and dry granulation machine that produces uniform compacted sheets with consistent hardness and increased density by compacting powdered material